OpenVSafe by OpenVAERS
Search V-safe

FAL-11866-40733

3 vaccinations 16 coded responses 40 check-ins 16 free-text entries 6 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
233 / VA
Registered
2020-12-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1807832 (opens in a new window) high 10 / 11 2 3 of 8 VAERS symptoms same dose (3) VA matches 2021-10-19 / 2021-10-20 / 2021-10-22
received the same day as the last call
case 1112320

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-28
    Registered in v-safe
  2. 2020-12-28
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-28
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Palpitations — Feeling: Fair · Site: Pain
    Free text: Heart racing sensation. Moderate symptom
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  7. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-02
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  11. 2021-01-04
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2021-01-11
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-18
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-18
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Heart racing sensation with heart rate at 152
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  20. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-01-25
    Health check-in — day 7, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  22. 2021-02-01
    Survey response — day 14, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue is terrible
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-04-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-04-20
    Pregnancy registry survey
    Pregnant after vaccination · Yes, I would like someone to contact me
  29. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-10-19
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  31. 2021-10-19
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  32. 2021-10-20
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, shortness of breath, heart rate up to 164
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-21
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Dyspnoea, Emergency care, Heart rate increased — Feeling: Poor · Site: Pain · Chills, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Chest pain shortness of breath elevated heart rate. Currently in ER
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-21
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  35. 2021-10-22
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Chest pain, shortness of breath, elevated heart rate. Severe
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-10-22
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  37. 2021-10-22
    Call successful
    Completed over the phone
  38. 2021-10-23
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, shortness of breath, elevated heart rate. Severe
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-10-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, shortness of breath, elevated heart rate - severe
    MedDRA releases: 2024-11 · check-in free text available
  40. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, shortness of breath, elevated heart rate. Severe
    MedDRA releases: 2024-11 · check-in free text available
  41. 2021-10-26
    Survey response — day 7, dose 3
    MedDRA: Chest pain, Dyspnoea, Heart rate increased — Feeling: Poor · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain, shortness of breath, elevated heart rate - severe
    MedDRA releases: 2024-11 · check-in free text available
  42. 2021-11-02
    Survey response — day 14, dose 3
    MedDRA: Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Worsening tachycardia
    MedDRA releases: 2024-11 · check-in free text available
  43. 2021-11-09
    Survey response — day 21, dose 3
    MedDRA: Chest pain, Dyspnoea, Presyncope, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Near Syncope. Continued chest pain, tachycardia, shortness of breath
    MedDRA releases: 2024-11 · check-in free text available
  44. 2021-11-16
    Survey response — day 28, dose 3
    MedDRA: Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Worsening tachycardia
    MedDRA releases: 2024-11 · check-in free text available
  45. 2021-11-16
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  46. 2021-11-17
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  47. 2021-11-23
    Survey response — day 35, dose 3
    MedDRA: Presyncope — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Pre-syncope
    MedDRA releases: 2024-11 · check-in free text available
  48. 2021-11-30
    Survey response — day 42, dose 3
    MedDRA: Loss of personal independence in daily activities, Muscular weakness, Presyncope, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Continue with tachycardia. Near syncope episodes. Upper extremity weakness post near syncope episode. Unable to perform daily tasks such as wash my hair.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2021-11-30
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  50. 2021-12-01
    Call successful
    Completed over the phone
  51. 2022-01-18
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  52. 2022-04-19
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  53. 2022-10-19
    Survey response — 12 months, dose 3
    MedDRA: Heart rate increased, Hospitalisation, Pneumonia, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Continue with tachycardia. Was recently hospitalized for pneumonia with elevated heart rate. Never hospitalized before.
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-10-19
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  55. 2022-10-20
  56. 2022-10-20
  57. 2022-10-20
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12020-12-28Pfizer-BioNTech
22021-01-18Pfizer-BioNTech
32021-10-19Pfizer-BioNTech Flu

Call center

6 call center cases

5 successful · 1 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 5

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-29

Systemic reaction (other): Heart racing sensation. Moderate symptom

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): Heart racing sensation with heart rate at 152

Release 3 — day 14, dose 2

2021-02-01

Symptoms: Fatigue is terrible

Release 10 — days 1–6 daily, dose 3

2021-10-20

Systemic reaction (other): Chest pain, shortness of breath, heart rate up to 164

2021-10-21

Systemic reaction (other): Chest pain shortness of breath elevated heart rate. Currently in ER

2021-10-22

Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate. Severe

2021-10-23

Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate. Severe

2021-10-24

Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate - severe

2021-10-25

Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate. Severe

Release 10 — day 7, dose 3

2021-10-26

Systemic reaction (other): Chest pain, shortness of breath, elevated heart rate - severe

Release 10 — day 14, dose 3

2021-11-02

Symptoms: Worsening tachycardia

Release 10 — day 21, dose 3

2021-11-09

Symptoms: Near Syncope. Continued chest pain, tachycardia, shortness of breath

Release 10 — day 28, dose 3

2021-11-16

Symptoms: Worsening tachycardia

Release 10 — day 35, dose 3

2021-11-23

Symptoms: Pre-syncope

Release 10 — day 42, dose 3

2021-11-30

Symptoms: Continue with tachycardia. Near syncope episodes. Upper extremity weakness post near syncope episode. Unable to perform daily tasks such as wash my hair.

Release 12 — 12 months, dose 3

2022-10-19

Symptoms: Continue with tachycardia. Was recently hospitalized for pneumonia with elevated heart rate. Never hospitalized before.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain · · ✓
SDDyspnoea · · ✓
SDFatigue ✓ ✓ ✓
SDHeart rate increased · · ✓
SDHospitalisation · · ✓
SDLoss of personal independence in daily activities · · ✓
SDMuscular weakness · · ✓
SDPneumonia · · ✓
SDPresyncope · · ✓
SDTachycardia · · ✓
SROChest pain · · ✓
SRODyspnoea · · ✓
SROEmergency care · · ✓
SROHeart rate increased · · ✓
SROPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release